AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday,…
ABBV
-
-
STOCK MARKET
AbbVie’s stock dips premarket after it lowers Q1 guidance to reflect dilutive impact of ImmunoGen deal close
by userby userAbbVie Inc.’s stock ABBV, -0.41% fell 0.5% early Monday, after the drug company lowered its…
-
STOCK MARKET
AbbVie’s fourth-quarter sales top estimates despite plunging Humira revenues
by userby userAbbVie Inc. ABBV, +1.94% on Friday reported fourth-quarter sales that topped analysts’ estimates, even as…
-
STOCK MARKET
GSK to buy asthma drug developer for up to $1.4 billion in pipeline push
by userby userGSK on Tuesday said it had struck a deal to acquire asthma drug developer Aiolos…
-
STOCK MARKET
Fusion Pharma climbs as radiopharmaceutical company flagged as potential merger target
by userby userFusion Pharmaceuticals Inc.’s stock was up by 5.3% in premarket trading on Wednesday, as analysts…
-
STOCK MARKET
These are the dividend stocks that will hold up in a weakening economy in 2024, says this highly rated money manager
by userby userDo you expect the U.S. economy to slip into a recession next year? If so,…
-
STOCK MARKET
There’s a new dynamic heading into payrolls report, Goldman trading expert says
by userby userIt was the day before payrolls, when all through the house, not an asset was…
-
STOCK MARKET
Medicare drug price negotiations move forward with all drugmakers participating, White House says
by userby userAll of the primary manufacturers of the 10 drugs selected in August for Medicare price…
-
STOCK MARKET
This fund shows that industry expertise can help you make a lot of money in the stock market
by userby userInvestors and the financial media have been fixated on exchange-traded funds for decades. The inexpensive…
-
STOCK MARKET
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
by userby userMedicare on Tuesday announced the first 10 drugs to be selected for a price-negotiation program…
- 1
- 2